Source: Manufacturing Chemist

Abzena: Abzena adds cell-based potency testing to its UK and US analytical service offering

The CDMO and CRO will now be able to develop GMP cell-based potency assays, which are crucial in measuring biopharmaceutical activity

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
250-500
Matthew Stober's photo - CEO of Abzena

CEO

Matthew Stober

CEO Approval Rating

82/100

Read more